McKesson distributes prescription drugs — branded, generic, and specialty — to retail pharmacy chains, independent pharmacies, mail-order pharmacies, and hospitals across the US and Canada. It is one of three companies (alongside Cencora and Cardinal Health) that together handle over 90% of US pharmaceutical wholesale volume. McKesson also sells medical-surgical supplies to healthcare facilities and offers pharmacy technology software. Revenue comes primarily from high-volume drug distribution with thin margins, supplemented by the medical supply and technology businesses.
Employees43,000IPOAug 3, 1987SIC5122HQ6555 State Highway 161, Irving, TX, USA, 75039
to
Financials
Profitability
Metric
Current
Margins
Gross Margin
3.6%
Operating Margin
1.7%
EBITDA Margin
1.8%
Net Margin
1.1%
OCF Margin
1.7%
FCF Margin
1.5%
Returns on Capital
ROE
—
ROA
5.5%
ROIC
21.1%
ROCE
40.8%
ROC (Greenblatt)
143.9%
3Y ROIIC
22.0%
Consistency
Years Profitable / 10Y
9
Valuation
Metric
Current
Earnings Multiples
P/E (TTM)
26.88
Forward P/E
22.50
P/E ex-NRI
24.62
Shiller P/E (CAPE)
76.14
Cash Flow Multiples
P/FCF
20.25
P/OCF
18.14
P/Owner Earnings
20.64
FCF Yield
5.25%
Enterprise Value Multiples
EV / EBIT
19.69
EV / Forward EBIT
17.71
EV / EBITDA
17.67
EV / Forward EBITDA
16.02
EV / Revenue
0.32
EV / Forward Revenue
0.30
Asset / Sales
P/S
0.30
P/B
—
P/Tangible Book
—
Growth-Adjusted
PEG
—
Capital Returns
Metric
Current
Dividends
Dividend Yield (TTM)
0.33%
Forward Dividend Yield
0.37%
3Y Dividend Growth
14.9%
Payout Ratio
0.08
5Y Yield on Cost
0.73%
Buybacks & Dilution
3Y Buyback Ratio
4.10%
5Y Share Change
−23.0%
Combined
Shareholder Yield
5.02%
Balance Sheet
Metric
Current
Leverage
Debt / Equity
−2.76
Gross Debt / EBITDA
1.56
Cash / Debt
0.44
Equity / Assets
−0.05
Coverage
Interest Coverage
24.70
Short-Term Liquidity
Current Ratio
0.89
Quick Ratio
0.52
Cash Ratio
0.07
Composite Scores
Piotroski F-Score
7
Altman Z-Score
5.84
Split History
Date
Split
1998-01-05
2:1
Ex-date
Amount
Pay date
2026-06-01
$0.82
2026-07-01
2026-03-02
$0.82
2026-04-01
2025-12-01
$0.82
2026-01-02
2025-09-02
$0.82
2025-10-01
2025-06-02
$0.71
2025-07-01
2025-03-03
$0.71
2025-04-01
2024-12-02
$0.71
2025-01-02
2024-08-30
$0.71
2024-10-01
2024-06-03
$0.62
2024-07-01
2024-02-29
$0.62
2024-04-01
10 of 170
View allDate
Transcript
Type
2026-08-05
Q1 2027 McKesson Corporation Earnings Conference Call
Earnings Call
2026-08-05
Q1 2027 McKesson Corp Earnings Call Transcript
Earnings Call
2026-05-07
Q4 2026 McKesson Corporation Earnings Conference Call
Earnings Call
2026-05-07
Q4 2026 McKesson Corp Earnings Call Transcript
Earnings Call
2026-03-11
McKesson Corp at Barclays Global Healthcare Conference Transcript
Conference Presentations
2026-03-11
McKesson Corp at Leerink Global Healthcare Conference Transcript
Conference Presentations
2026-02-04
Q3 2026 McKesson Corporation Earnings Conference Call
Earnings Call
2026-02-04
Q3 2026 McKesson Corp Earnings Call Transcript
Earnings Call
2026-01-13
McKesson Corp at JPMorgan Healthcare Conference Transcript
Conference Presentations
2025-12-04
McKesson Corp at Evercore ISI Healthcare Conference Transcript
Conference Presentations
10 of 85
5-Step DuPont Analysis
ROE %
-147.96%
×
×
Net Margin %
1.12%
×
×
Operating Margin %
1.65%
Operating Income
$6.79B
÷
Revenue
$410.98B
×
Tax Burden
0.7111
Net Income
$4.59B
÷
Pretax Income
$6.46B
×
Interest Burden
0.9508
Pretax Income
$6.46B
÷
Operating Income
$6.79B
×
Asset Turnover
4.85
÷
Revenue
$410.98B
÷
Average Total Assets
$84.82B
Begin Total Assets
$81.31B
End Total Assets
$88.33B
×
Equity Multiplier
-27.33
÷
Avg Total Assets
$84.82B
÷
Avg Stockholders Equity
−$3.10B
Begin Equity
−$1.97B
End Equity
−$4.24B
Top institutional holders
Q2 2026| Holder | Shares | % Owned | Chg. shares | |
|---|---|---|---|---|
| BlackRock, Inc. | 10.8M | 8.81% | -623.3K | $8.16B |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.9M | 6.41% | -107.6K | $5.93B |
| STATE STREET CORP | 5.7M | 4.68% | -4.6K | $4.33B |
| MORGAN STANLEY | 5.3M | 4.33% | +3.0M | $4.01B |
| FRANKLIN RESOURCES INC | 2.9M | 2.37% | -158.0K | $2.20B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.9M | 2.35% | -9.9K | $2.17B |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8M | 2.30% | -81.7K | $2.12B |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.4M | 2.00% | -453.8K | $1.86B |
| FMR LLC | 2.1M | 1.74% | -1.5M | $1.61B |
| JPMORGAN CHASE & CO | 1.7M | 1.43% | -1.5M | $1.31B |
10 of 2,030
View allTop insider holdings
as reported| Insider | Shares held | % Owned | |
|---|---|---|---|
| Vitalone Britt J.Officer | 22.0K | 0.0179% | $22.06M |
| Fraga FranciscoOfficer | 6.2K | 0.0051% | $6.24M |
| TYLER BRIAN S.Officer | 5.9K | 0.0048% | $5.95M |
| Smith LeAnn BOfficer | 4.8K | 0.0039% | $4.82M |
| Lau MicheleOfficer | 3.2K | 0.0027% | $3.26M |
| Rodgers Thomas LOfficer | 2.3K | 0.0019% | $2.28M |
| Caruso Dominic JDirector | 927 | 0.0008% | $931.5K |
| Martinez MariaDirector | 578 | 0.0005% | $580.8K |
| Wilson-Thompson KathleenDirector | 578 | 0.0005% | $580.8K |
| Rutledge Napoleon B JROfficer | 521 | 0.0004% | $523.5K |
10 of 11
View allRecent insider activity
through Sep 8, 2026| Insider | Action | Shares | Date | |
|---|---|---|---|---|
| Rutledge Napoleon B JROfficer | Open-Market or Private Sale | -111 | $99.0K | Sep 8, 2026 |
| Lerman Bradley EDirector | Open-Market or Private Sale | -301 | $268.6K | Aug 10, 2026 |
| Wilson-Thompson KathleenDirector | Grant/Award (Rule 16b-3(d)) | +277 | $225.5K | Jul 22, 2026 |
| Caruso Dominic JDirector | Grant/Award (Rule 16b-3(d)) | +277 | $225.5K | Jul 22, 2026 |
| Martinez MariaDirector | Grant/Award (Rule 16b-3(d)) | +277 | $225.5K | Jul 22, 2026 |
| TYLER BRIAN S.Officer | Open-Market or Private Sale | -8.5K | $6.72M | Jul 7, 2026 |
| TYLER BRIAN S.Officer | Open-Market or Private Sale | -8.5K | $6.56M | Jun 17, 2026 |
| TYLER BRIAN S.Officer | Open-Market or Private Sale | -4.9K | $3.76M | Jun 9, 2026 |
| Rutledge Napoleon B JROfficer | Open-Market or Private Sale | -133 | $101.6K | Jun 5, 2026 |
| Rodgers Thomas LOfficer | Open-Market or Private Sale | -699 | $514.0K | Jun 2, 2026 |
10 of 2,151
View all